Reference Type:  Journal Article
Record Number: 781
Author: Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L. L., Imboywa, S., Lee, M., Von Korff, A., Alzheimer Disease Neuroimaging, Initiative, Morris, M. C., Evans, D. A., Johnson, K., Sperling, R. A., Schneider, J. A., Bennett, D. A. and De Jager, P. L.
Year: 2013
Title: CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Journal: Nat Neurosci
Volume: 16
Issue: 7
Pages: 848-50
Date: Jul
Short Title: CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Alternate Journal: Nature neuroscience
ISSN: 1546-1726 (Electronic)
1097-6256 (Linking)
DOI: 10.1038/nn.3435
PMCID: 3703870
Accession Number: 23708142
Keywords: Adult
Age Factors
Aged
Aged, 80 and over
Alzheimer Disease/genetics/*pathology/radionuclide imaging
Amyloid beta-Peptides/*metabolism
Aniline Compounds/diagnostic use
Brain/pathology/radionuclide imaging
Cohort Studies
Dextrans/metabolism
Female
Genetic Association Studies
Genotype
HLA-D Antigens/metabolism
Humans
Male
Microglia/pathology
Middle Aged
Mild Cognitive Impairment/metabolism/pathology
Monocytes/*metabolism
Peptide Fragments/*metabolism
Plaque, Amyloid/pathology
Polymorphism, Genetic/genetics
Sialic Acid Binding Ig-like Lectin 3/genetics/*metabolism
Thiazoles/diagnostic use
Young Adult
Abstract: In our functional dissection of the CD33 Alzheimer's disease susceptibility locus, we found that the rs3865444(C) risk allele was associated with greater cell surface expression of CD33 in the monocytes (t50 = 10.06, P(joint) = 1.3 x 10(-13)) of young and older individuals. It was also associated with diminished internalization of amyloid-beta 42 peptide, accumulation of neuritic amyloid pathology and fibrillar amyloid on in vivo imaging, and increased numbers of activated human microglia.
Notes: Bradshaw, Elizabeth M
Chibnik, Lori B
Keenan, Brendan T
Ottoboni, Linda
Raj, Towfique
Tang, Anna
Rosenkrantz, Laura L
Imboywa, Selina
Lee, Michelle
Von Korff, Alina
Morris, Martha C
Evans, Denis A
Johnson, Keith
Sperling, Reisa A
Schneider, Julie A
Bennett, David A
De Jager, Philip L
eng
K25 AG041906/AG/NIA NIH HHS/
P30 AG010161/AG/NIA NIH HHS/
P30 AG10161/AG/NIA NIH HHS/
R01 AG011101/AG/NIA NIH HHS/
R01 AG015819/AG/NIA NIH HHS/
R01 AG017917/AG/NIA NIH HHS/
R01 AG030146/AG/NIA NIH HHS/
R01 AG031553/AG/NIA NIH HHS/
R01 AG036042/AG/NIA NIH HHS/
R01 AG043617/AG/NIA NIH HHS/
R01 AG11101/AG/NIA NIH HHS/
R01 AG15819/AG/NIA NIH HHS/
R01 AG17917/AG/NIA NIH HHS/
R01 AG30146/AG/NIA NIH HHS/
R10 NS067305/NS/NINDS NIH HHS/
RC2 GM093080/GM/NIGMS NIH HHS/
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
2013/05/28 06:00
Nat Neurosci. 2013 Jul;16(7):848-50. doi: 10.1038/nn.3435. Epub 2013 May 23.
URL: http://www.ncbi.nlm.nih.gov/pubmed/23708142
Author Address: Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.


